Little Boy With Prader-Willi Syndrome Starts Human Growth Hormone Therapy

Two year-old Junior Takehara of Gig Harbor is getting nightly HGH shots to treat a rare genetic condition that causes chronic hunger. Did you eat your dinner tonight? If not, your stomach's probably growling right about now. Imagine what that would feel like all of the time. That's what a Gig Harbor boy deals with every day.

ISWG researchers establish guidelines for diagnosis and treatment of infantile spasms

Researchers from across the U.S., as part of the Infantile Spasms Working Group (ISWG), established guidelines for the diagnosis and treatment of infantile spasms (IS). The goal of the ISWG is to improve patient outcomes by creating protocols that educate pediatricians on early diagnosis and treatment options. Full details of this study appear online in Epilepsia, a journal published by Wiley ...

UB symposium to discuss In Silico molecular design, High-throughput screening to treat diseases

Twenty-first-century pharmaceutical breakthroughs require 21st-century drug discovery tools, such as computational or in silico molecular design and high-throughput screening of effective, new compounds. That's the theme of a University at Buffalo symposium to be held Sept. 11 on "Twenty-first Century Bioscience: In Silico Methods and High-Throughput Screening," which will feature a variety of ...

Prolor Biotech gets US FDA clearance for phase II trial of its long-acting human growth hormone in US

Prolor Biotech, Inc., a company developing next generation biobetter therapeutic proteins, announced that it has received regulatory clearance from the US Food and Drug Administration (FDA) to conduct a phase II clinical trial in the US of its longer-acting version of human growth hormone, hGH-CTP.

Physicians HGH Center

[PR.com]